Kirk Tanner
Company: National Brain Tumor Society
Job title: CSO
Seminars:
Chair’s Opening Remarks 8:35 am
day: Conference Day 1
Chair’s Closing Remarks 5:30 pm
day: Conference Day 1
Chair’s Opening Remarks 8:25 am
day: Conference Day 2
Delaying Disease Progression & Boosting Therapeutic Efficacy By Targeting the DNA Damage Response 5:00 pm
Reviewing the landscape of DDR targeted approaches Targeting DDR mechanisms to enhance efficacy of other treatments Tackling the incorporation of DDR agents from a regulatory standpointRead more
day: Conference Day 2
Chair’s Closing Remarks 5:30 pm
day: Conference Day 2